We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer (SPARTAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01946204
Recruitment Status : Active, not recruiting
First Posted : September 19, 2013
Last Update Posted : February 8, 2018
Information provided by (Responsible Party):
Aragon Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : May 19, 2017
  Estimated Study Completion Date : August 29, 2019